A. Durak Et Al. , "An Investigation on Molecular Basis of the Effects of SGLT2 İnhibitor Dapagliflozin on Hyperglycemia-Associated Heart Dysfunction," Journal of Ankara University Faculty of Medicine , vol.71, no.3, pp.131-138, 2018
Durak, A. Et Al. 2018. An Investigation on Molecular Basis of the Effects of SGLT2 İnhibitor Dapagliflozin on Hyperglycemia-Associated Heart Dysfunction. Journal of Ankara University Faculty of Medicine , vol.71, no.3 , 131-138.
Durak, A., OLĞAR, Y., DEĞİRMENCİ, S., Ertürk, N., AKBAŞ, M. T., AYGÜN, A., ... DENİZ, M. C.(2018). An Investigation on Molecular Basis of the Effects of SGLT2 İnhibitor Dapagliflozin on Hyperglycemia-Associated Heart Dysfunction. Journal of Ankara University Faculty of Medicine , vol.71, no.3, 131-138.
Durak, Ayşegül Et Al. "An Investigation on Molecular Basis of the Effects of SGLT2 İnhibitor Dapagliflozin on Hyperglycemia-Associated Heart Dysfunction," Journal of Ankara University Faculty of Medicine , vol.71, no.3, 131-138, 2018
Durak, Ayşegül Et Al. "An Investigation on Molecular Basis of the Effects of SGLT2 İnhibitor Dapagliflozin on Hyperglycemia-Associated Heart Dysfunction." Journal of Ankara University Faculty of Medicine , vol.71, no.3, pp.131-138, 2018
Durak, A. Et Al. (2018) . "An Investigation on Molecular Basis of the Effects of SGLT2 İnhibitor Dapagliflozin on Hyperglycemia-Associated Heart Dysfunction." Journal of Ankara University Faculty of Medicine , vol.71, no.3, pp.131-138.
@article{article, author={Ayşegül Durak Et Al. }, title={An Investigation on Molecular Basis of the Effects of SGLT2 İnhibitor Dapagliflozin on Hyperglycemia-Associated Heart Dysfunction}, journal={Journal of Ankara University Faculty of Medicine}, year=2018, pages={131-138} }